Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilis.
Fimbriae of the human uropathogen Proteus mirabilis are the only characterized surface proteins that contribute to its virulence by mediating adhesion and invasion of the uroepithelia. PMI2122 (AipA) and PMI2575 (TaaP) are annotated in the genome of strain HI4320 as trimeric autotransporters with "adhesin-like" and "agglutinating adhesin-like" properties, respectively. The C-terminal 62 amino acids (aa) in AipA and 76 aa in TaaP are homologous to the translocator domains of YadA from Yersinia enterocolitica and Hia from Haemophilus influenzae. Comparative protein modeling using the Hia three-dimensional structure as a template predicted that each of these domains would contain four antiparallel beta sheets and that they formed homotrimers. Recombinant AipA and TaaP were seen as ∼28 kDa and ∼78 kDa, respectively, in Escherichia coli, and each also formed high-molecular-weight homotrimers, thus supporting this model. E. coli synthesizing AipA or TaaP bound to extracellular matrix proteins with a 10- to 60-fold-higher level of affinity than the control strain. Inactivation of aipA in P. mirabilis strains significantly (P < 0.01) reduced the mutants' ability to adhere to or invade HEK293 cell monolayers, and the functions were restored upon complementation. A 51-aa-long invasin region in the AipA passenger domain was required for this function. E. coli expressing TaaP mediated autoagglutination, and a taaP mutant of P. mirabilis showed significantly (P < 0.05) more reduced aggregation than HI4320. Gly-247 in AipA and Gly-708 in TaaP were indispensable for trimerization and activity. AipA and TaaP individually offered advantages to P. mirabilis in a murine model. This is the first report characterizing trimeric autotransporters in P. mirabilis as afimbrial surface adhesins and autoagglutinins.
Alamuri
Praveen
P
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109-0620, USA.
Löwer
Martin
M
Hiss
Jan A
JA
Himpsl
Stephanie D
SD
Schneider
Gisbert
G
Mobley
Harry L T
HL
D018829:Adhesins, Bacterial / Q000235:genetics / Q000378:metabolism*; D000371:Agglutination; D000595:Amino Acid Sequence; D000818:Animals; D001422:Bacterial Adhesion; D019281:Dimerization; D005260:Female; D010861:Fimbriae, Bacterial / Q000378:metabolism; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D008808:Mice, Inbred CBA; D008969:Molecular Sequence Data; D011512:Proteus Infections / Q000382:microbiology; D011513:Proteus mirabilis / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity* / Q000502:physiology; D014552:Urinary Tract Infections / Q000382:microbiology*
D018829:Adhesins, Bacterial; D008565:Membrane Proteins
Microbes Infect. 2007 Jun;9(7):821-8
17540603
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W197-201
18463136
Infect Immun. 1993 Jul;61(7):2748-54
8514376
Kidney Int Suppl. 1994 Nov;47:S129-36
7869662
Int J Antimicrob Agents. 2002 Jun;19(6):461-5
12135833
Mol Microbiol. 1997 Mar;23(5):1009-19
9076737
Microbiol Mol Biol Rev. 2004 Dec;68(4):692-744
15590781
Infect Immun. 2004 Dec;72(12):6961-8
15557618
Mol Microbiol. 2008 May;68(4):997-1017
18430084
Microbes Infect. 2004 Jul;6(9):853-60
15374007
BMC Microbiol. 2007 Mar 15;7:19
17362501
Nature. 1996 May 23;381(6580):272
8692262
Mol Microbiol. 2006 Aug;61(3):631-44
16803596
Microbes Infect. 2000 Jul;2(9):1061-72
10967286
Infect Immun. 2009 Feb;77(2):632-41
19029299
Bioinformatics. 2007 Nov 1;23(21):2947-8
17846036
Res Microbiol. 2004 Mar;155(2):53-60
14990256
Infect Immun. 2008 Sep;76(9):4222-31
18625734
FEMS Immunol Med Microbiol. 2007 Oct;51(1):1-7
17640292
Trends Microbiol. 2005 May;13(5):199-205
15866036
Infect Immun. 2010 Jun;78(6):2677-90
20308293
Mol Microbiol. 1993 Dec;10(5):995-1011
7934875
Mol Microbiol. 2000 Jul;37(1):192-206
10931316
EMBO J. 2000 Jun 15;19(12):2803-12
10856226
Microbes Infect. 2000 Oct;2(12):1497-505
11099936
Infect Immun. 1998 Sep;66(9):4374-81
9712790
Biochem Cell Biol. 2001;79(6):783-8
11800020
Mol Membr Biol. 2007 Jan-Feb;24(1):28-40
17453411
EMBO J. 2006 Jun 7;25(11):2297-304
16688217
J Biol Chem. 2001 Oct 19;276(42):39492-500
11504735
Infect Immun. 2004 Sep;72(9):5159-67
15322010
Infect Immun. 2008 Nov;76(11):4859-64
18725420
Infect Immun. 1998 Apr;66(4):1791-4
9529116
J Bacteriol. 2008 Jun;190(11):4027-37
18375554
J Bacteriol. 2007 Dec;189(24):9011-9
17921300
FEMS Microbiol Lett. 2007 Sep;274(2):163-72
17610513
Appl Microbiol Biotechnol. 2006 Feb;69(6):607-14
16369779
J Bacteriol. 2008 Jun;190(12):4147-61
18424525
Infect Immun. 2009 Feb;77(2):896-903
19015250
Mol Microbiol. 1996 Mar;19(6):1215-23
8730864
Urol Res. 1993;21(6):407-11
8171763
Mol Microbiol. 1999 May;32(4):825-36
10361285
Infect Immun. 2010 Jun;78(6):2823-33
20385754
Trends Microbiol. 2000 Dec;8(12):529-32
11115743
J Med Microbiol. 1999 Jun;48(6):527-534
10359301
Infect Immun. 2001 Mar;69(3):1231-43
11179284
Infect Immun. 1991 Oct;59(10):3778-86
1894376
J Bacteriol. 2003 Jul;185(13):3735-44
12813066
Microbiol Mol Biol Rev. 1997 Mar;61(1):65-89
9106365
FEMS Immunol Med Microbiol. 2007 Nov;51(2):319-26
17714491
Infect Immun. 1990 Oct;58(10):3330-6
1976113
Clin Microbiol Rev. 2008 Jan;21(1):26-59
18202436
J Bacteriol. 2006 Aug;188(15):5400-7
16855229
Infect Immun. 1992 Nov;60(11):4740-6
1398984
Res Microbiol. 2006 Jun;157(5):407-16
16725315
J Biol Chem. 2004 Apr 9;279(15):14679-85
14726537
Infect Immun. 2004 Jan;72(1):66-75
14688082
J Bacteriol. 2008 Feb;190(4):1459-72
18065547